Related Experiment Videos
Mindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial
Susan A Gaylord1, William E Whitehead, Rebecca S Coble
1Program on Integrative Medicine, Department of Physical Medicine and Rehabilitation, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. susan_gaylord@med.unc.edu
BMC Complementary and Alternative Medicine
|July 30, 2009
Summary
Mindfulness training shows feasibility for treating Irritable Bowel Syndrome (IBS) symptoms. This study assessed mindfulness-based stress reduction (MBSR) in women with IBS, comparing it to a social support group.
Area of Science:
- Gastroenterology
- Behavioral Medicine
- Clinical Psychology
Background:
- Irritable Bowel Syndrome (IBS) affects 10% of U.S. adults, causing significant disability and burden.
- Conventional treatments offer partial symptom relief.
- Behavioral interventions like mindfulness training are promising for IBS management.
Purpose of the Study:
- To assess the feasibility and efficacy of mindfulness training for Irritable Bowel Syndrome (IBS).
- To evaluate a mindfulness-based stress reduction (MBSR) protocol adapted for IBS patients.
Main Methods:
- A randomized controlled trial comparing an 8-week mindfulness training group to an IBS social-support group.
- Adult women meeting Rome II criteria for IBS were enrolled.
- The IBS Symptom Severity Scale was used to measure primary outcomes.
Main Results:
- The study demonstrated feasibility for conducting a rigorous randomized clinical trial.
- A standardized MBSR protocol adapted for IBS was utilized.
- A control social-support group, previously used in IBS studies, served as the comparison.
Conclusions:
- It is feasible to conduct a randomized clinical trial of mindfulness training for IBS.
- The adapted MBSR protocol is suitable for IBS patients.
- Mindfulness training presents a viable behavioral treatment option for IBS.
Related Concept Videos
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:17Irritable Bowel Syndrome I: Introduction
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:23Irritable Bowel Syndrome
DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...